It’s only a week until DIA19 in beautiful San Diego! If you are going to be there and would like to meet the Karma Oncology team, go along to Stand 2550 and hear how we can help you with your Oncology Clinical Development Program. For an appointment to meet our Founder & CEO Dr Karen
The Karma Oncology team are getting ready for DIA19 in San Diego, 23rd -27th June. If you are going to be there please come along to Stand 2550 and meet the Karma Oncology team to learn how we can help you with your Oncology Clinical Development Program. For an appointment contact clinical@karmaoncology2.uk.w3pcloud.com Karma Oncology
Karma Oncology is coming up to a very busy quarter! Karma Oncology will again be travelling all over the world to attend all the Big BIO Events for the end of the year including BIOPHARMA AMERICA BIO JAPAN and BIO-EUROPE. Will you be there? Contact our Business Development Manager Dr Kara Kennedy (kara.kennedy@karmaoncology2.uk.w3pcloud.com) to catch
https://immuno-oncologynews.com/immuno-oncology/?amp
Cancer – it is one of the world’s most pressing healthcare challenges and something that most of us have some form of a connection with at some-point throughout our lifetime. We are living in a dynamic moment in time for oncology treatment where 2018 brings us many clinical advancements for the treatment options for Cancer.
CAR-T cell therapy has been able to effectively treat cancer in some patients for whom all other treatment options were exhausted. However, the technology still has a long road ahead before becoming a widespread treatment option. Read this insightful interview with Christian CEO of Celyad. Read More Here: https://labiotech.eu/car-t-cell-therapy-cancer-celyad/
Karma Oncology are always keeping up to date with the latest Biotech news and treatments on the market. We attend many events each year and always make sure we attend ASCO -the biggest oncology conference in the world. Here is a link to the highlights of the event. https://labiotech-eu.cdn.ampproject.org/c/s/labiotech.eu/european-cancer-research-asco-2018/amp/
The novel immunotherapy that is CAR-T seems to be the hot topic of the oncology market and has held it’s place there for quite some time. However, there are major safety issues when it comes to this immuno-oncology therapy. This article gives some insights into how scientists are trying to understand and overcome the safety
Link to an interesting article posted by The Scientist on how sex can implement the effectiveness of Immunotherapy in Cancer. Interesting Read! Link below: https://www.the-scientist.com/?articles.amp/articleNo/54614/title/Immunotherapy-More-Effective-in-Men–Study/&__twitter_impression=true/
Thanks to Cytel here is an insight into what to expect from the fantastic line up at #ASCO from the likes of Cell Medica. http://bit.ly/2rX2XpQ